Surgery for Hypertrophic Obstructive Cardiomyopathy
DOI:
https://doi.org/10.2015/hc.v4i2.327Abstract
Surgical treatment of hypertrophic obstructive cardiomyopathy (HOCM) comprises septal myectomy which though has been limited to patients with refractory symptoms and high resting gradients. Results of surgical intervention are well documented with dramatic reduction in left ventricular outflow tract gradient and resultant relief of symptoms in about 95% of patients. Transcoronary ablation of septal hypertrophy with alcohol is a newer percutaneous technique, designed to ablate hypertrophied cardiac septal muscle through localized infarction, but its efficacy compared with that of surgical myectomy is uncertain. In the present article we briefly review the technique of septal myectomy and compare it with septal ablation, concluding that the standard septal myectomy still remains the preferred and proven therapy.Downloads
Issue
Section
License
Authors who publish with this journal agree to the following terms:a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).